MbrlCatalogueTitleDetail

Do you wish to reserve the book?
595. Olorofim (OLO) for treatment of invasive mould infections in patients with limited or no treatment options: PK data from a Phase 2b open-label study (NCT03583164, Study 32)
595. Olorofim (OLO) for treatment of invasive mould infections in patients with limited or no treatment options: PK data from a Phase 2b open-label study (NCT03583164, Study 32)
by Rex, John H , Cornelissen, Karen , Chen, Sharon C , Wright, James G , Maertens, Johan A , Cristinacce, Andrew , Galbraith, Hal , Thompson, George R , Bruggemann, Roger
2022
Yes Please
Hey, we have placed the reservation for you!
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Done
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Done
Are you sure you want to remove the book from the shelf?
595. Olorofim (OLO) for treatment of invasive mould infections in patients with limited or no treatment options: PK data from a Phase 2b open-label study (NCT03583164, Study 32)
by Rex, John H , Cornelissen, Karen , Chen, Sharon C , Wright, James G , Maertens, Johan A , Cristinacce, Andrew , Galbraith, Hal , Thompson, George R , Bruggemann, Roger
in
2022
Confirm
Oops! Something went wrong.
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Done
Title added to your shelf!
Title added to your shelf!
View what I already have on My Shelf.
Thanks
Oops! Something went wrong.
Oops! Something went wrong.
While trying to add the title to your shelf something went wrong :( Kindly try again later!
Done
Do you wish to request the book?
595. Olorofim (OLO) for treatment of invasive mould infections in patients with limited or no treatment options: PK data from a Phase 2b open-label study (NCT03583164, Study 32)
595. Olorofim (OLO) for treatment of invasive mould infections in patients with limited or no treatment options: PK data from a Phase 2b open-label study (NCT03583164, Study 32)
by Rex, John H , Cornelissen, Karen , Chen, Sharon C , Wright, James G , Maertens, Johan A , Cristinacce, Andrew , Galbraith, Hal , Thompson, George R , Bruggemann, Roger
2022

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
How would you like to get it?
We have requested the book for you! Sorry the robot delivery is not available at the moment
Submit
We have requested the book for you!
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Done
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Done
Mohammed Bin Rashid Library /
Catalogue /
595. Olorofim (OLO) for treatment of invasive mould infections in patients with limited or no treatment options: PK data from a Phase 2b open-label study (NCT03583164, Study 32)
595. Olorofim (OLO) for treatment of invasive mould infections in patients with limited or no treatment options: PK data from a Phase 2b open-label study (NCT03583164, Study 32)
Journal Article

595. Olorofim (OLO) for treatment of invasive mould infections in patients with limited or no treatment options: PK data from a Phase 2b open-label study (NCT03583164, Study 32)

Rex, John H,
Cornelissen, Karen,
Chen, Sharon C,
Wright, James G,
Maertens, Johan A,
Cristinacce, Andrew,
Galbraith, Hal,
Thompson, George R,
Bruggemann, Roger
2022
Request Book From Autostore and Choose the Collection Method
Share this book
Add to My Shelf

MBRLCatalogueRelatedBooks

Related Items

Related Items

We currently cannot retrieve any items related to this title. Kindly check back at a later time.